A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis

Summary

To preliminarily evaluate the clinical efficacy of the renin inhibitor SPH3127 Tablets in patients with mild to moderate ulcerative colitis with placebo as a control and determine the recommended dose.

Timeline

Start

2023-06-19

Primary completion

2024-09-13

Completion

2024-09-13

Drugs

Indications